New Tech Offers Objective Autism Diagnosis

Traditional autism diagnostic tools often rely on subjective observations, caregiver reports, or clinician interpretation, leading to variability. A new wave of technology-based tools is addressing this by measuring objective biomarkers associated with autism.

Research has established that differences in visual attention are among the earliest and most reliable autism biomarkers. Eye-tracking technology quantifies these differences by measuring where a child looks, for how long, and in what sequence. This approach provides direct, objective measurement of looking behavior, eliminating the interpretive layers present in subjective assessments like ADOS-2, ADI-R, or CARS-2.

Administered by trained technicians, these assessments generate reports with diagnostic scores and interpretations. Clinicians then integrate this objective data with other information for a final diagnosis. This model enhances efficiency and helps reduce the bottleneck in traditional evaluation methods. Furthermore, artificial intelligence is being used to analyze behavioral data, with several digital diagnostic aids receiving regulatory clearance.